Byung-soo Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes.

The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes.

Journal: Endocrinology
Published: May 23, 2024

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma.

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma.

Journal: Biomedicines
Published: March 22, 2022

Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma.

Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma.

Journal: Stem cell research
Published: March 09, 2022

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma.

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma.

Journal: Stem cell research
Published: February 12, 2022

A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia.

A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia.

Journal: Stem cell research
Published: January 04, 2022

Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3.

Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3.

Journal: Stem cell research
Published: November 05, 2021

Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient.

Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient.

Journal: Stem cell research
Published: June 16, 2021

Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia.

Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia.

Journal: Stem cell research
Published: June 16, 2021

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation.

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation.

Journal: Stem cell research
Published: September 15, 2020

Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.

Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.

Journal: Cancer immunology research
Published: August 13, 2020

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium.

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium.

Journal: Data in brief
Published: July 13, 2020

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium.

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium.

Journal: Stem cell research
Published: June 02, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026